Iovance Biotherapeutics had a revenue of 59.95M in the quarter ending Jun 30, 2025, with 21.55%. This bring the company's revenue in the last twelve months to 241.52M, Decreased 13.56%. In the fiscal year ending Dec 31, 2024, Iovance Biotherapeutics had annual revenue of 164.07M with 13698.99% growth.